Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Karan, Dixit"'
Autor:
Priya Kumthekar, Madison Lyleroehr, Leilani Lacson, Rimas V. Lukas, Karan Dixit, Roger Stupp, Timothy Kruser, Jeff Raizer, Alexander Hou, Sean Sachdev, Margaret Schwartz, Jessica Bajas PA, Ray Lezon, Karyn Schmidt, Christina Amidei, Karen Kaiser
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Tumor Treating Fields (TTFields) Therapy is an FDA-approved therapy in the first line and recurrent setting for glioblastoma. Despite Phase 3 evidence showing improved survival with TTFields, it is not uniformly utilized. We aimed
Externí odkaz:
https://doaj.org/article/d7895edb0e734564b205c572113db00c
Autor:
Matthew McCord, Pouya Jamshidi, Vineeth Thirunavu, Lucas Santana-Santos, Erica Vormittag-Nocito, David Dittman, Stephanie Parker, Joseph Baczkowski, Lawrence Jennings, Jordain Walshon, Kathleen McCortney, Kristyn Galbraith, Hui Zhang, Rimas V. Lukas, Roger Stupp, Karan Dixit, Priya Kumthekar, Amy B. Heimberger, Matija Snuderl, Craig Horbinski
Publikováno v:
Acta Neuropathologica Communications, Vol 11, Iss 1, Pp 1-15 (2023)
Abstract MGMT promoter methylation testing is required for prognosis and predicting temozolomide response in gliomas. Accurate results depend on sufficient tumor cellularity, but histologic estimates of cellularity are subjective. We sought to determ
Externí odkaz:
https://doaj.org/article/c76fde180aa142ce9de66226ad2f660b
Autor:
Karan Dixit, Lauren Singer, Sean Aaron Grimm, Rimas V. Lukas, Margaret A. Schwartz, Alfred Rademaker, Hui Zhang, Masha Kocherginsky, Sofia Chernet, Laura Sharp, Valerie Nelson, Jeffrey J. Raizer, Priya Kumthekar
Publikováno v:
Cancers, Vol 16, Iss 11, p 2133 (2024)
Patients with solid tumor brain metastases that progress after whole-brain radiation have limited options. This prospective trial investigated the efficacy, safety, and tolerability of bevacizumab as salvage therapy in this population. Eligible patie
Externí odkaz:
https://doaj.org/article/ee17767657894c5296dc32fc11b7adcc
Autor:
Adam M Sonabend, Andrew Gould, Christina Amidei, Rachel Ward, Karyn A Schmidt, Daniel Y Zhang, Cristal Gomez, John F Bebawy, Benjamin P Liu, Guillaume Bouchoux, Carole Desseaux, Irene B Helenowski, Rimas V Lukas, Karan Dixit, Priya Kumthekar, Víctor A Arrieta, Maciej S Lesniak, Alexandre Carpentier, Hui Zhang, Miguel Muzzio, Michael Canney, Roger Stupp
Publikováno v:
The Lancet Oncology. 24:509-522
Autor:
Priya U Kumthekar, Michael J Avram, Andrew B Lassman, Nancy U Lin, Eudocia Lee, Sean A Grimm, Margaret Schwartz, Kirsten L Bell Burdett, Rimas V Lukas, Karan Dixit, Isabella Perron, Hui Zhang, William J Gradishar, Elena I Pentsova, Suriya Jeyapalan, Morris D Groves, Michelle Melisko, Jeffrey J Raizer
Publikováno v:
Neuro-Oncology. 25:557-565
Background Patients with human epidermal growth factor receptor 2-positive (HER2-positive) cancers have a high incidence of central nervous system (CNS) spread, but unfortunately systemic trastuzumab which targets the HER2 receptor has little CNS pen
Autor:
Ella N. Perrault, Jack M. Shireman, Eunus S. Ali, Peiyu Lin, Isabelle Preddy, Cheol Park, Shreya Budhiraja, Shivani Baisiwala, Karan Dixit, C. David James, Dieter H Heiland, Issam Ben-Sahra, Sebastian Pott, Anindita Basu, Jason Miska, Atique U. Ahmed
Publikováno v:
Science Advances. 9
During therapy, adaptations driven by cellular plasticity are partly responsible for driving the inevitable recurrence of glioblastoma (GBM). To investigate plasticity-induced adaptation during standard-of-care chemotherapy temozolomide (TMZ), we per
Publikováno v:
Thursday, April 27.
Autor:
Derek A. Wainwright, David H. Munn, George C. Prendergast, Ursula Grohmann, Judith Campisi, Graham Pawelec, Changyou Zhou, Min Wei, Craig Horbinski, Rimas V. Lukas, Karan Dixit, Jeffrey J. Raizer, Priya Kumthekar, Robert M. Prins, Aaron Y. Mochizuki, Leonidas C. Platanias, Joseph R. Podojil, Jennifer D. Wu, Bin Zhang, Masha Kocherginsky, Jiahui Xu, April Bell, Kristen L. Lauing, Lijie Zhai, Erik Ladomersky
Supplemental Figure 5. Confirmation of gut microbiota depletion.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c406912952ef4df99e3435065c2d59
https://doi.org/10.1158/1078-0432.22477865.v1
https://doi.org/10.1158/1078-0432.22477865.v1
Autor:
Derek A. Wainwright, David H. Munn, George C. Prendergast, Ursula Grohmann, Judith Campisi, Graham Pawelec, Changyou Zhou, Min Wei, Craig Horbinski, Rimas V. Lukas, Karan Dixit, Jeffrey J. Raizer, Priya Kumthekar, Robert M. Prins, Aaron Y. Mochizuki, Leonidas C. Platanias, Joseph R. Podojil, Jennifer D. Wu, Bin Zhang, Masha Kocherginsky, Jiahui Xu, April Bell, Kristen L. Lauing, Lijie Zhai, Erik Ladomersky
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d3350aa320ffb492921fca7f272bb58
https://doi.org/10.1158/1078-0432.22477883
https://doi.org/10.1158/1078-0432.22477883
Autor:
Derek A. Wainwright, David H. Munn, George C. Prendergast, Ursula Grohmann, Judith Campisi, Graham Pawelec, Changyou Zhou, Min Wei, Craig Horbinski, Rimas V. Lukas, Karan Dixit, Jeffrey J. Raizer, Priya Kumthekar, Robert M. Prins, Aaron Y. Mochizuki, Leonidas C. Platanias, Joseph R. Podojil, Jennifer D. Wu, Bin Zhang, Masha Kocherginsky, Jiahui Xu, April Bell, Kristen L. Lauing, Lijie Zhai, Erik Ladomersky
Supplemental Figure 6. Characterization of the potent clinical-grade IDO enzyme inhibitor, BGB-7204.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::173f2030ce97d7e239f622881e8045c6
https://doi.org/10.1158/1078-0432.22477859
https://doi.org/10.1158/1078-0432.22477859